![Rapid Response COVID-19 Antigen Detection Test box with pouch and cassette](https://strategicstrike.blob.core.windows.net/lochness-products/staging/COV-19COPU_1.png)
![Rapid Response COVID-19 Antigen Detection Test pouch and cassette](https://strategicstrike.blob.core.windows.net/lochness-products/staging/COV-19COPU_2.png)
![Rapid Response COVID-19 Antigen Detection Test box](https://strategicstrike.blob.core.windows.net/lochness-products/staging/COV-19COPU_3.png)
![Rapid Response COVID-19 Antigen Detection Test box with pouch and cassette](https://strategicstrike.blob.core.windows.net/lochness-products/staging/COV-19COPU_1.png)
![Rapid Response COVID-19 Antigen Detection Test pouch and cassette](https://strategicstrike.blob.core.windows.net/lochness-products/staging/COV-19COPU_2.png)
![Rapid Response COVID-19 Antigen Detection Test box](https://strategicstrike.blob.core.windows.net/lochness-products/staging/COV-19COPU_3.png)
The Rapid Response™ COVID-19 Antigen Detection Test is a lateral flow immunochromatographic assay intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal swabs specimens from individuals with signs and symptoms of upper respiratory infection within the first six (6) days of symptom onset. The test is intended for use as an aid in the diagnosis of SARS-CoV-2 infections (COVID-19) in symptomatic individuals when either: tested at least twice over three days with at least 48 hours between tests; or when tested once, and negative by the Rapid Response™ COVID-19 Antigen Detection Test and followed with a molecular test.
The test does not differentiate between SARS-CoV and SARS-CoV-2.
- 20 Test cassettes
- 20 Sterile swabs
- 20 Pre-filled buffer tubes with flip-top
- 2 Tube holders
- Instructions for Use
- Quick Reference Guide
The Rapid Response™ COVID-19 Antigen Detection Test is a lateral flow immunochromatographic assay intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigens directly in anterior nasal swabs specimens from individuals with signs and symptoms of upper respiratory infection within the first six (6) days of symptom onset. The test is intended for use as an aid in the diagnosis of SARS-CoV-2 infections (COVID-19) in symptomatic individuals when either: tested at least twice over three days with at least 48 hours between tests; or when tested once, and negative by the Rapid Response™ COVID-19 Antigen Detection Test and followed with a molecular test.
The test does not differentiate between SARS-CoV and SARS-CoV-2.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.